Product Name :Strontium Ranelate

Other Name:StrontiuM Ranelic

CAS No.:135459-87-9

Molecular Formula:C12H6N2O8SSr2

Molecular Weight:513.491g/mol

Purity : 99% HPLC

Appearance: White to light yellow crystalline Powder

Typical use:Postmenopausal osteoporosis Treatments

Shelf Life :2 years

Payment Terms:T/T, Western Union, Money Gram
Storage:Room temperature keep dry and away from light.

Strontium ranelate is an antiosteoporotic agent which both increases bone formation and reduces bone resorption, resulting in a rebalance of bone turnover in favor of bone formation. This is similar to the effects of choline-stabilized orthosilicic acid.

Strontium ranelate, a strontium(II) salt of ranelic acid , is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee.The drug is unusual in that it both increases deposition of new bone byosteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA).
It is mainly used to treat and prevent osteoporosis in postmenopausal women and significantly reduce the risk of vertebral and hip fractures. It is clinically mainly used for the treatment and prevention of osteoporosis in postmenopausal women with significantly reducing the risk of occurrence of vertebral fractures and hip fractures.